These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7357804)

  • 1. Antiarrhythmic effects of flecainide.
    Somani P
    Clin Pharmacol Ther; 1980 Apr; 27(4):464-70. PubMed ID: 7357804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerance of intravenous flecainide in patients with chronic high frequency ventricular arrhythmias.
    Stroobandt R; Andries E; van Mieghem W; Kesteloot H
    Eur Heart J; 1984 Nov; 5(11):876-82. PubMed ID: 6397356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of flecainide acetate in the treatment of premature ventricular contractions.
    Abitbol H; Califano JE; Abate C; Beilis P; Castellanos H
    Am Heart J; 1983 Feb; 105(2):227-30. PubMed ID: 6823803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of complex ventricular arrhythmias by oral flecainide.
    Duran D; Platia EV; Griffith LS; Adhar G; Reid PR
    Clin Pharmacol Ther; 1982 Nov; 32(5):554-61. PubMed ID: 7127996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral flecainide for suppression of ventricular arrhythmias.
    Vanhaleweyk G; Balakumaran K; Lubsen J; Roelandt J; Hugenholtz PG
    Cardiology; 1984; 71(1):30-9. PubMed ID: 6722846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes.
    Kjekshus J; Bathen J; Orning OM; Storstein L
    Am J Cardiol; 1984 Feb; 53(5):72B-78B. PubMed ID: 6421140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flecainide versus quinidine: results of a multicenter trial.
    Hodges M; Salerno DM; Granrud G
    Am J Cardiol; 1984 Feb; 53(5):66B-71B. PubMed ID: 6364770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Flecainide: a new antiarrhythmic agent].
    Leclercq JF; Coumel P
    Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1218-30. PubMed ID: 6418100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral flecainide acetate for the treatment of ventricular arrhythmias.
    Anderson JL; Stewart JR; Perry BA; Van Hamersveld DD; Johnson TA; Conard GJ; Chang SF; Kvam DC; Pitt B
    N Engl J Med; 1981 Aug; 305(9):473-7. PubMed ID: 7019711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flecainide: a new prototype antiarrhythmic agent.
    Nappi JM; Anderson JL
    Pharmacotherapy; 1985; 5(4):209-21. PubMed ID: 3898035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term antiarrhythmic therapy with flecainide.
    Meinertz T; Zehender MK; Geibel A; Treese N; Hofmann T; Kasper W; Pop T
    Am J Cardiol; 1984 Jul; 54(1):91-6. PubMed ID: 6741844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent.
    Hodges M; Haugland JM; Granrud G; Conard GJ; Asinger RW; Mikell FL; Krejci J
    Circulation; 1982 May; 65(5):879-85. PubMed ID: 7074749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flecainide: a new agent for the treatment of ventricular arrhythmias.
    Grubb BP; Tilley-Gray B
    Am J Med Sci; 1986 Sep; 292(3):160-3. PubMed ID: 3529958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proarrhythmic effects of the new antiarrhythmic agent flecainide acetate.
    Nathan AW; Hellestrand KJ; Bexton RS; Banim SO; Spurrell RA; Camm AJ
    Am Heart J; 1984 Feb; 107(2):222-8. PubMed ID: 6695656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flecainide acetate: concentration-response relationships for antiarrhythmic and electrocardiographic effects.
    Boriani G; Capucci A; Strocchi E; Calliva R; Santarelli A; Biffi M; Magnani B
    Int J Clin Pharmacol Res; 1993; 13(4):211-9. PubMed ID: 8150547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial.
    Circulation; 1983 May; 67(5):1117-23. PubMed ID: 6339110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of flecainide on chronic ventricular arrhythmias (author's transl)].
    Bluschke V; Breithardt G; Abendroth RR; Seipel L
    Z Kardiol; 1982 Apr; 71(4):284-8. PubMed ID: 6178228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A proposal for the clinical use of flecainide.
    Anderson JL; Stewart JR; Crevey BJ
    Am J Cardiol; 1984 Feb; 53(5):112B-119B. PubMed ID: 6364767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of flecainide with quinidine for suppression of chronic stable ventricular ectopic depolarizations. A double-blind randomized study in ambulatory outpatients.
    Salerno DM; Hodges M; Granrud G; Sharkey P
    Ann Intern Med; 1983 Apr; 98(4):455-60. PubMed ID: 6340575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flecainide: a new antiarrhythmic drug.
    Med Lett Drugs Ther; 1986 Feb; 28(707):19-20. PubMed ID: 3951388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.